Model NO.: 188627-80-7
Trademark: YCGC
Transport Package: 10g/Western Bottle Can Not Be Split
Specification: 10G/Western bottle can not be split
Origin: China
HS Code: 12345677
Model NO.: 188627-80-7
Trademark: YCGC
Transport Package: 10g/Western Bottle Can Not Be Split
Specification: 10G/Western bottle can not be split
Origin: China
HS Code: 12345677
Product Details
Eptifibatide
Product Name:Eptifibatide
CAS:188627-80-7
MF:C35H49N11O9S2
MW:831.96
Usage:A Arginin-glycin-aspartat-mimetic, reversibly binds to platelets to reduce the risk of cardiac ischemic events.
 
Appearance White crystalline powder
Package 1g/aluminium foil bag or as required
Usage can be used as weightloss
Minimum order quantity 1g
passment Professional team special for package and shipment and staring
  on tracking code 24hours for customs pass guaranteed
Shipping By express courier
Shipping leading time Within 24 hours after receiving the payment
Payment options Western Union, MoneyGram, T/T,Bank transfer
shipping 1)Express delivery with DHL,EMS,FedEx,HKEMS,TNT,UPS
  (Express delivery within 24 hours after payment)
  2)By sea (large quantity ,it will take 30-45days)
Price Negotiated
Supply ability 50g/Month


Brief introduction:
 
Eptifibatide (Integrilin, Millennium Pharmaceuticals, also co-promoted by Schering-Plough/Essex), is an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class.[1] Eptifibatide is a cyclic heptapeptide derived from a protein found in the venom of the southeastern pygmy rattlesnake (Sistrurus miliarius barbouri). It belongs to the class of the so-called arginin-glycin-aspartat-mimetics and reversibly binds to platelets. Eptifibatide has a short half-life. The drug is the third inhibitor of GPIIb/IIIa that has found broad acceptance after the specific antibody abciximab and the non-peptide tirofiban entered the global market.
 
Indications
 
Eptifibatide is used to reduce the risk of acute cardiac ischemic events (death and/or myocardial infarction) in patients with unstable angina or non-ST-segment-elevation (e.g., non-Q-wave) myocardial infarction (I.e., non-ST-segment elevation acute coronary syndromes) both in patients who are to receive non surgery (conservative) medical treatment and those undergoing percutaneous coronary intervention (PCI).
 
The drug is usually applied together with aspirin or clopidogrel and (low molecular weight or unfractionated) heparin. Additionally, the usual supportive treatment consisting of applications of nitrates, beta-blockers, opioid analgesics and/or benzodiazepines should be employed as indicated. Angiographic evaluation and other intensive diagnostic procedures may be considered a first line task before initiating therapy with eptifibatide.
 
The drug should exclusively be used in hospitalized patients both because of the serious degree of patients' illness and because of the possible side-effects of eptifibatide.
 
Contraindications and precautions
 
Thrombocytopenia : The drug is contraindicated in patients with platelet counts of less than 100,000 per μl because no clinical experience exists regarding such patients.
Renal insufficiency : Eptifibatide undergoes renal elimination. In such patients with renal insufficiency where a glycoprotein IIb/IIIa inhibitor is likely to provide benefit, Abciximab (trade name: Reopro) is an alternative medication.
Current bleeding tendencies or abnormally prolonged coagulation parameters observed within 30 days before starting therapy with eptifibatide is intended.
Coagulation parameters such as ACT, aPTT, TT, and PT should be followed closely during therapy and afterwards.
Allergy to eptifibatide and/or other ingredients.
Severe, uncontrolled hypertension.
Pregnancy : No experience exists. Pregnant patients should be treated only when clearly needed.
Lactation : No human data exists. Breast-feeding should be avoided during treatment in order to prevent damage to the newborn.
Geriatric patients : No differences in side effects compared with younger patients have been seen. Nevertheless, geriatric patients should be very closely observed for bleeding and other side-effects.
Pediatric patients : Eptifibatide is not indicated in patients below 18 years of age, because no experience exists


Product Image
Raw Peptide Powder Eptifibatide for Weight Loss (188627-80-7)
More products:
CAS NAME
137-58-6    Lidocaine
73-78-9 Lidocaine Hydrochloride
51-05-8 Procaine Hydrochloride
614-39-1   Procainamide Hydrochloride
94-09-7     Benzocaine
59-46-1 Procaine
94-24-6     Tetracaine
1786-81-8   Propitocaine Hydrochloride
637-58-1   Pramoxine Hydrochloride
721-50-6 Prilocaine
14252-80-3     Levobupivacaine Hydrochloride
23964-57-0 Articaine Hydrochloride
2180-92-9 Bupivacaine
136-47-0 Tetracaine Hydrochloride
98717-15-8 Ropivacaine Hydrochloride
1722-62-9 Carbocaine Hydrochloride
22801-44-1    Mepivacaine Base
1027-14-1   Trimecaine
85-79-0 Dibucaine
854056-07-8 Ropivacaine Mesylate
27262-47-1    Levobupivacaine
553-63-9 Larocaine HCl
94-15-5   DimethoCaine
5875-06-9 Proparacaine Hydrochloride
5987-82-6 Oxybuprocaine Hydrochloride
Package picture
Raw Peptide Powder Eptifibatide for Weight Loss (188627-80-7)
Factory Photo 
Raw Peptide Powder Eptifibatide for Weight Loss (188627-80-7)

                                                             COA
ITEMS SPECIFICATION TESTRESULTS
Appearance Off-white or white powder Conforms
Identification HPLC,NMR;LC-MS Conforms
Related substances Individual impurity≤0.5% 0.09%
Total impurities≤1.0% 0.20%
Loss on drying ≤0.5% 0.3%
Residue on ignition ≤0.1% 0.04%
Heavy metals ≤10ppm Conforms
Assay ≥98.0 % 99.1%
Our advantage 
1. We have experience in exporting steroids, as you know, EU places much emphasis on them, and you must find a experienced partner who will assure you; 
2. Quality: Our company is a professional leading factory in China in pharmaceutical area, We had stable customers and exported to Germany, Spain, UK, USA, Australia, Middle East, and any other countries. We can provide good references about our company. As for the quality of the products, we 're sure they can satisfy you well enough; 
3. Package: Professional packing with professional materials 
4. Delivery: We have products in stock, and we will deliver them soon when your PO arrived. Meanwhile we will give you the tracking number in order to make you know the exact location of the products. We will keep track of the product until they arrive you; We choose the best courier service for you, and with the delivery around 5-7 working days. 
5. Service: Best Service with after-sales service and consultation
Raw Peptide Powder Eptifibatide for Weight Loss (188627-80-7)

If you want to know more about our products,please search

http://www.slsteroid.com/.

Product Details
Eptifibatide
Product Name:Eptifibatide
CAS:188627-80-7
MF:C35H49N11O9S2
MW:831.96
Usage:A Arginin-glycin-aspartat-mimetic, reversibly binds to platelets to reduce the risk of cardiac ischemic events.
 
Appearance White crystalline powder
Package 1g/aluminium foil bag or as required
Usage can be used as weightloss
Minimum order quantity 1g
passment Professional team special for package and shipment and staring
  on tracking code 24hours for customs pass guaranteed
Shipping By express courier
Shipping leading time Within 24 hours after receiving the payment
Payment options Western Union, MoneyGram, T/T,Bank transfer
shipping 1)Express delivery with DHL,EMS,FedEx,HKEMS,TNT,UPS
  (Express delivery within 24 hours after payment)
  2)By sea (large quantity ,it will take 30-45days)
Price Negotiated
Supply ability 50g/Month


Brief introduction:
 
Eptifibatide (Integrilin, Millennium Pharmaceuticals, also co-promoted by Schering-Plough/Essex), is an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class.[1] Eptifibatide is a cyclic heptapeptide derived from a protein found in the venom of the southeastern pygmy rattlesnake (Sistrurus miliarius barbouri). It belongs to the class of the so-called arginin-glycin-aspartat-mimetics and reversibly binds to platelets. Eptifibatide has a short half-life. The drug is the third inhibitor of GPIIb/IIIa that has found broad acceptance after the specific antibody abciximab and the non-peptide tirofiban entered the global market.
 
Indications
 
Eptifibatide is used to reduce the risk of acute cardiac ischemic events (death and/or myocardial infarction) in patients with unstable angina or non-ST-segment-elevation (e.g., non-Q-wave) myocardial infarction (I.e., non-ST-segment elevation acute coronary syndromes) both in patients who are to receive non surgery (conservative) medical treatment and those undergoing percutaneous coronary intervention (PCI).
 
The drug is usually applied together with aspirin or clopidogrel and (low molecular weight or unfractionated) heparin. Additionally, the usual supportive treatment consisting of applications of nitrates, beta-blockers, opioid analgesics and/or benzodiazepines should be employed as indicated. Angiographic evaluation and other intensive diagnostic procedures may be considered a first line task before initiating therapy with eptifibatide.
 
The drug should exclusively be used in hospitalized patients both because of the serious degree of patients' illness and because of the possible side-effects of eptifibatide.
 
Contraindications and precautions
 
Thrombocytopenia : The drug is contraindicated in patients with platelet counts of less than 100,000 per μl because no clinical experience exists regarding such patients.
Renal insufficiency : Eptifibatide undergoes renal elimination. In such patients with renal insufficiency where a glycoprotein IIb/IIIa inhibitor is likely to provide benefit, Abciximab (trade name: Reopro) is an alternative medication.
Current bleeding tendencies or abnormally prolonged coagulation parameters observed within 30 days before starting therapy with eptifibatide is intended.
Coagulation parameters such as ACT, aPTT, TT, and PT should be followed closely during therapy and afterwards.
Allergy to eptifibatide and/or other ingredients.
Severe, uncontrolled hypertension.
Pregnancy : No experience exists. Pregnant patients should be treated only when clearly needed.
Lactation : No human data exists. Breast-feeding should be avoided during treatment in order to prevent damage to the newborn.
Geriatric patients : No differences in side effects compared with younger patients have been seen. Nevertheless, geriatric patients should be very closely observed for bleeding and other side-effects.
Pediatric patients : Eptifibatide is not indicated in patients below 18 years of age, because no experience exists


Product Image
Raw Peptide Powder Eptifibatide for Weight Loss (188627-80-7)
More products:
CAS NAME
137-58-6    Lidocaine
73-78-9 Lidocaine Hydrochloride
51-05-8 Procaine Hydrochloride
614-39-1   Procainamide Hydrochloride
94-09-7     Benzocaine
59-46-1 Procaine
94-24-6     Tetracaine
1786-81-8   Propitocaine Hydrochloride
637-58-1   Pramoxine Hydrochloride
721-50-6 Prilocaine
14252-80-3     Levobupivacaine Hydrochloride
23964-57-0 Articaine Hydrochloride
2180-92-9 Bupivacaine
136-47-0 Tetracaine Hydrochloride
98717-15-8 Ropivacaine Hydrochloride
1722-62-9 Carbocaine Hydrochloride
22801-44-1    Mepivacaine Base
1027-14-1   Trimecaine
85-79-0 Dibucaine
854056-07-8 Ropivacaine Mesylate
27262-47-1    Levobupivacaine
553-63-9 Larocaine HCl
94-15-5   DimethoCaine
5875-06-9 Proparacaine Hydrochloride
5987-82-6 Oxybuprocaine Hydrochloride
Package picture
Raw Peptide Powder Eptifibatide for Weight Loss (188627-80-7)
Factory Photo 
Raw Peptide Powder Eptifibatide for Weight Loss (188627-80-7)

                                                             COA
ITEMS SPECIFICATION TESTRESULTS
Appearance Off-white or white powder Conforms
Identification HPLC,NMR;LC-MS Conforms
Related substances Individual impurity≤0.5% 0.09%
Total impurities≤1.0% 0.20%
Loss on drying ≤0.5% 0.3%
Residue on ignition ≤0.1% 0.04%
Heavy metals ≤10ppm Conforms
Assay ≥98.0 % 99.1%
Our advantage 
1. We have experience in exporting steroids, as you know, EU places much emphasis on them, and you must find a experienced partner who will assure you; 
2. Quality: Our company is a professional leading factory in China in pharmaceutical area, We had stable customers and exported to Germany, Spain, UK, USA, Australia, Middle East, and any other countries. We can provide good references about our company. As for the quality of the products, we 're sure they can satisfy you well enough; 
3. Package: Professional packing with professional materials 
4. Delivery: We have products in stock, and we will deliver them soon when your PO arrived. Meanwhile we will give you the tracking number in order to make you know the exact location of the products. We will keep track of the product until they arrive you; We choose the best courier service for you, and with the delivery around 5-7 working days. 
5. Service: Best Service with after-sales service and consultation
Raw Peptide Powder Eptifibatide for Weight Loss (188627-80-7)

If you want to know more about our products,please search

http://www.slsteroid.com/.

We can customize different size bale net for you to fit any sized bale.

If your bale size is 4` high by 5` wide then you need a MEDIUM SIZED NET that measures 5` x 7`.

If your bale size is 5` high by 6` wide then you need a LARGE SIZED NET that measures 6` x 8`.


bale net for baler

1.23m Width Bale Wrap Netting

1.23m Width*3000m(4') bale wrap netting, silage bale net, corn wrap netting

Zibo Maoyang Industry and Trading Co.,ltd , http://www.mysilage.com